A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Clinical trial NCT07213791 · RECRUITING

Trial details

NCT number: NCT07213791
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Neoplasms Breast Neoplasms Pancreatic Intraductal Neoplasms Colorectal Neoplasms Esophageal Neoplasms Stomach Neoplasms Cholangiocarcinoma

Start date: 2025-10-22
Primary completion: 2028-07-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.